🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Site Reference ID/Investigator# 20081
Start Date
2009-05
Trial ID
NCT00909636
The purpose of this study was to assess the safety, tolerability, pharmacok...
Status
Completed
Location
Site Reference ID/Investigator# 16103
Start Date
2009-03
Trial ID
NCT00851890
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of ABT-450...
Status
Completed
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT01715415
This is a 1:1 randomized double-blind Placebo-controlled moncenter Phase IV...
Status
Terminated
Location
Hannover Medical School
Start Date
2017-10-24
Trial ID
NCT03003338
Treatments Being Tested
The purpose of this study is to evaluate the safety and antiviral activity ...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01833533
Treatments Being Tested
This is a study to evaluate ABT 450/r/ABT-267 and ABT-333 in treatment-naïv...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02517515
The purpose of this study is to evaluate the safety and efficacy of ABT-450...
Status
Completed
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT01716585
The purpose of this study is to assess the safety, tolerability, pharmacoki...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00696904
The purpose of this study is to evaluate the safety and antiviral activity ...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01767116
Treatments Being Tested
This study assessed the safety, tolerability, pharmacokinetics, and antivir...
Status
Completed
Location
Site Reference ID/Investigator# 23392
Start Date
2010-03
Trial ID
NCT01074008